Category: Biotech
-
Biohaven (BHVN.NYSE), Zosano Pharma (ZSAN.Q), Lundbeck (HLUYY.OTC) tackle a $41 billion problem that cruelly targets women
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S. and 1 billion worldwide.”
-
![Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?]()
Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?
When a sector gets hot, small cap stocks can often get a bump by sidling up to the hot sector with a new product/idea/opportunity. When the dust clears, the intrinsic value of the new offering is typically deemed to be low. We saw it in 3D-printing, with Dung Beetle Treats. We saw it in weed…
-
AMPD, PAT, MTA, HIVE, MILE: Contrarian investing as the zombies climb over the walls
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show host with a penchant for scams didn’t make a clever President, Italy is in total lockdown, the Japanese are thinking of holding a spectator-free Olympics, Israel is putting anyone coming…
-
Moderna’s (MRNA.Q) “Coronavirus Vaccine” announcement – causes $3.4 billion jump in market cap
We’ll take a wild guess that precisely NONE of the retail investors who just drove up the price of the MRNA would recognise a “stabilized form of S protein” if they met it on a beach, made sand castles with it – then took it home to play Spin-The-Bottle.
-
![vTv Therapeutics (VTVT.Q) surges 55% on type 1 diabetes drug trial]()
vTv Therapeutics (VTVT.Q) surges 55% on type 1 diabetes drug trial
“A once-a-day pill that reduces HbA1c and improves time in range with continuous glucose monitoring, without increasing hypoglycemia or any signal for adverse events, is a big win for the future care of type 1 diabetes,” stated clinical researcher Dr. John Buse.
-
![Resverlogix (RVX.T), Sirona Biochem (SBM.V), Sernova (SVA.V): 3 Canadian biotechs tackle a $330 billion health crisis]()
Resverlogix (RVX.T), Sirona Biochem (SBM.V), Sernova (SVA.V): 3 Canadian biotechs tackle a $330 billion health crisis
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP.
-
![Coronavirus freak-out: global markets just paid $3 trillion for a bowl of weak peacock soup]()
Coronavirus freak-out: global markets just paid $3 trillion for a bowl of weak peacock soup
A Wuhan market price list offers 112 types of wild critters including peacocks, foxes, giant salamanders, snakes, rats, porcupines and camel meat.
-
![Acceleron (XLRN.Q) gains $1.3 billion in market cap after successful phase ll trial]()
Acceleron (XLRN.Q) gains $1.3 billion in market cap after successful phase ll trial
Acceleron is finding solutions for serious and rare diseases. It has a pipeline of products moving towards commercialisation, including a co-promotion with the $152 billion Bristol-Myers Squibb (BMY.NYSE)
-
![BioTech Breakthrough: why is Greenpeace turning its back on 350,000 blind children?]()
BioTech Breakthrough: why is Greenpeace turning its back on 350,000 blind children?
With offices in 41 countries, 2.8 million members and a patriarchal structure, Greenpeace has global revenue of USD $300 million. Its most successful fundraising catalysts have been images of beautiful animals about to be slaughtered.
-
![Indignant Pharma CEO explains why the Lower Drug Costs Now Act is a terrible thing]()
Indignant Pharma CEO explains why the Lower Drug Costs Now Act is a terrible thing
“Americans spend more on prescription drugs than anyone else in the world,” states Bloomberg, “It’s true that they take a lot of pills. But what really sets the U.S. apart from most other countries is high prices.” Cancer drugs in the U.S. routinely cost $10,000 a month. The cost for old drugs has spiked, as…
